Bowman Consulting Group Ltd
For the period ended Jun 30, 2024. Filed Aug 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
During the quarter ended June 30, 2024, the following director and officers of the Company each adopted atrading arrangement for the sale of securities of the Company’s common stock (each, a “10b5-1 Plan”) that is intended to satisfy the affirmative defense conditions of the Securities Exchange Rule Act 10b5-1(c):
On May 13, 2024, Patricia Mulroy, a Director of the Company, adopted a 10b5-1 Plan that provides for the sale of up to 1,400 shares of the Company’s common stock pursuant to the terms of the 10b5-1 Plan from August 12, 2024 through September 2024. Ms. Mulroy’s prior 10b5-1 Plan expired by its terms in August 2023.
On May 15, 2024, Stephen Riddick, a Director of the Company, adopted a 10b5-1 Plan that provides for the sale of up to 6,600 shares of the Company’s common stock pursuant to the terms of the 10b5-1 Plan from August 14, 2024 through August 2025.
On May 17, 2024, Robert A. Hickey, the Company’s Chief Legal Officer and Secretary, adopted a 10b5-1 Plan that provides for the sale of up to 45,000 shares of the Company’s common stock pursuant to the terms of the 10b5-1 Plan from August 19, 2024 through July 2025. Mr. Hickey’s prior 10b5-1 Plan expired by its terms in May 2024.
On May 28, 2024, Michael Bruen, the Company’s President and Director, adopted a 10b5-1 Plan that provides for (i) the sale of up to 25,000 shares of the Company’s common stock pursuant to the terms of the 10b5-1 Plan and (ii) a gift of 7,500 shares of the Company's common stock pursuant to the terms of the 10b5-1 Plan, in each case from September 2024 through February 2025. Mr. Bruen’s prior 10b5-1 Plan expires by its terms in August 2024.
On June 12, 2024, Bruce Labovitz, the Company’s Chief Financial Officer, adopted a 10b5-1 Plan that provides for the sale of up to 30,000 shares of the Company’s common stock pursuant to the terms of the 10b5-1 Plan pursuant to the terms of the 10b5-1 Plan from September 16, 2024 through April 2025. Mr. Labovitz’s prior 10b5-1 Plan expired by its terms in April 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.